v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 69,919 $ 76,021
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 40,962 33,523
Amortization of debt issuance costs 1,180 1,562
Loss on sale of business 3,916 0
Share-based compensation 6,851 8,133
Amortization of intangible assets 20,577 38,515
Deferred income taxes (6,647) 2,574
Loss on equity investments, net 0 13,287
Other non-cash gain/(loss), net 5,175 (4,184)
Changes in operating assets and liabilities, net of the effects of divestitures:    
Accounts receivable, net (34,101) (19,156)
Inventories (47,986) (8,677)
Prepaid expenses and other current assets (8,512) (8,920)
Accounts payable and accrued expenses 64,832 (29,447)
Income taxes payable 2,602 1,809
Other 431 1,447
Net cash provided by operating activities 119,199 106,487
Cash flows from investing activities:    
Additions to property, plant and equipment and capitalized software (32,575) (42,130)
Proceeds from the sale of business, net of cash sold 25,635 0
Other 66 0
Net cash used in investing activities (6,874) (42,130)
Cash flows from financing activities:    
Payment of employee restricted stock tax withholdings (61) (129)
Payments on debt (685) (279)
Dividends paid (17,901) (18,056)
Payments to repurchase ordinary shares (100,500) (10,052)
Purchase of noncontrolling interest in joint venture 0 (79,393)
Payments of debt financing costs 0 (39)
Net cash used in financing activities (119,147) (107,948)
Effect of exchange rate changes on cash and cash equivalents 1,291 (4,154)
Net change in cash and cash equivalents (5,531) (47,745)
Cash and cash equivalents, beginning of year 593,670 508,104
Cash and cash equivalents, end of period $ 588,139 $ 460,359